Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Cambridge Innovation Capital I Limited investment portfolio
Cambridge Innovation Capital I Limited has made numerous investments in companies such as Immutrin, Storm Therapeutics, and Pervasid within the Biotech sector.
vc
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Immutrin Ltd IMMUTRIN LTD is a biotechnology company that conducts research and experimental development within the field of biotechnology. This work involves the systematic study of biological systems and living organisms to develop or modify products and processes for specific applications. | BiotechHealth Tech | Confirmed | 2025-09-19 |
| Pervasid Limited PERVASID LIMITED designs and supplies next-generation passive RFID tag reading solutions, such as their TrackMaster system, for automating inventory tracking, stock taking, and asset management processes. Their technology is utilized across various sectors including retail, industrial manufacturing, warehousing & logistics, healthcare, financial organizations, and automotive & aviation manufacturers. | DeepTechHardware | Confirmed | 2026-03-10 |
Shareholding changes (4)
Cambridge Innovation Capital I Limited's positions across portfolio companies2025
- SERIES SEED-4 PREFERRED 0 → 12,500
2024
- B1 PREFERRED 1,227,070 → 0
- B2 PREFERRED 1,640,884 → 0
- DEFERRED 0 → 2,581,159
- ORDINARY 0 → 286,795
Articles (3)
- 25 May 2026
- 13 May 2026
- Storm Therapeutics secures £9.2m for clinical stage RNA research9 May 2026Storm Therapeutics